HSPA5 mRNA levels increase 253-fold than that of ACE2 in lung cancer, indicating that HSPA5 migh play more important roles for SARS-Cov-2 entry in cancer patients through the lungs. This evidence concerns the gene HSPA5 and lung carcinoma.